Cargando…
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for signi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954694/ https://www.ncbi.nlm.nih.gov/pubmed/35337173 http://dx.doi.org/10.3390/ph15030376 |
_version_ | 1784676156931309568 |
---|---|
author | El-Kalyoubi, Samar A. Ragab, Ahmed Abu Ali, Ola A. Ammar, Yousry A. Seadawy, Mohamed G. Ahmed, Aya Fayed, Eman A. |
author_facet | El-Kalyoubi, Samar A. Ragab, Ahmed Abu Ali, Ola A. Ammar, Yousry A. Seadawy, Mohamed G. Ahmed, Aya Fayed, Eman A. |
author_sort | El-Kalyoubi, Samar A. |
collection | PubMed |
description | The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for significant effectiveness in the clinical treatment of COVID-19 patients, despite the worsening trends of COVID-19. This study aims to design a simple and efficient cyclo-condensation reaction of 6-aminouracil derivatives 2a–e and isatin derivatives 1a–c to synthesize spiro-oxindoles 3a–d, 4a–e, and 5a–e. All compounds were tested in vitro against the SARS-CoV-2. Four spiro[indoline-3,5′-pyrido[2,3-d:6,5-d’]dipyrimidine derivatives 3a, 4b, 4d, and 4e showed high activities against the SARS-CoV-2 in plaque reduction assay and were subjected to further RNA-dependent-RNA-polymerase (RdRp) and spike glycoprotein inhibition assay investigations. The four compounds exhibited potent inhibitory activity ranging from 40.23 ± 0.09 to 44.90 ± 0.08 nM and 40.27 ± 0.17 to 44.83 ± 0.16 nM, respectively, when compared with chloroquine as a reference standard, which showed 45 ± 0.02 and 45 ± 0.06 nM against RdRp and spike glycoprotein, respectively. The computational study involving the docking studies of the binding mode inside two proteins ((RdRp) (PDB: 6m71), and (SGp) (PDB: 6VXX)) and geometrical optimization used to generate some molecular parameters were performed for the most active hybrids. |
format | Online Article Text |
id | pubmed-8954694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89546942022-03-26 One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein El-Kalyoubi, Samar A. Ragab, Ahmed Abu Ali, Ola A. Ammar, Yousry A. Seadawy, Mohamed G. Ahmed, Aya Fayed, Eman A. Pharmaceuticals (Basel) Article The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for significant effectiveness in the clinical treatment of COVID-19 patients, despite the worsening trends of COVID-19. This study aims to design a simple and efficient cyclo-condensation reaction of 6-aminouracil derivatives 2a–e and isatin derivatives 1a–c to synthesize spiro-oxindoles 3a–d, 4a–e, and 5a–e. All compounds were tested in vitro against the SARS-CoV-2. Four spiro[indoline-3,5′-pyrido[2,3-d:6,5-d’]dipyrimidine derivatives 3a, 4b, 4d, and 4e showed high activities against the SARS-CoV-2 in plaque reduction assay and were subjected to further RNA-dependent-RNA-polymerase (RdRp) and spike glycoprotein inhibition assay investigations. The four compounds exhibited potent inhibitory activity ranging from 40.23 ± 0.09 to 44.90 ± 0.08 nM and 40.27 ± 0.17 to 44.83 ± 0.16 nM, respectively, when compared with chloroquine as a reference standard, which showed 45 ± 0.02 and 45 ± 0.06 nM against RdRp and spike glycoprotein, respectively. The computational study involving the docking studies of the binding mode inside two proteins ((RdRp) (PDB: 6m71), and (SGp) (PDB: 6VXX)) and geometrical optimization used to generate some molecular parameters were performed for the most active hybrids. MDPI 2022-03-20 /pmc/articles/PMC8954694/ /pubmed/35337173 http://dx.doi.org/10.3390/ph15030376 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article El-Kalyoubi, Samar A. Ragab, Ahmed Abu Ali, Ola A. Ammar, Yousry A. Seadawy, Mohamed G. Ahmed, Aya Fayed, Eman A. One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title | One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title_full | One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title_fullStr | One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title_full_unstemmed | One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title_short | One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
title_sort | one-pot synthesis and molecular modeling studies of new bioactive spiro-oxindoles based on uracil derivatives as sars-cov-2 inhibitors targeting rna polymerase and spike glycoprotein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954694/ https://www.ncbi.nlm.nih.gov/pubmed/35337173 http://dx.doi.org/10.3390/ph15030376 |
work_keys_str_mv | AT elkalyoubisamara onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT ragabahmed onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT abualiolaa onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT ammaryousrya onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT seadawymohamedg onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT ahmedaya onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein AT fayedemana onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein |